SELE and neoplasm: A thioaptamer targeting E-selectin (ESTA-1) (109) demonstrated selective binding with nanomolar binding affinity, and was able to target porous silicon particles to the tumor vasculature in a breast cancer xenograft model, endothelium of bone marrow or atherosclerotic plaque (104–106).